<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04390698</url>
  </required_header>
  <id_info>
    <org_study_id>OFA</org_study_id>
    <nct_id>NCT04390698</nct_id>
  </id_info>
  <brief_title>Opioid Free Anesthesia in Breast Cancer Surgery</brief_title>
  <official_title>Opioid Free Anesthesia in Breast Cancer Surgery: a Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University People's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A comparison of incidences of postoperative nausea and vomiting (PONV) , postoperative pain&#xD;
      severity and recovery parameters in breast cancer patients receiving opioid or opioid-free&#xD;
      general anesthesia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Breast cancer is one of the most common oncologic diagnosis in women. Surgery is&#xD;
      traditionally performed under general anesthesia with opioid-based analgesia. It is&#xD;
      associated with higher incidences of PONV, more severe acute postoperative pain and increased&#xD;
      incidences of chronic pain. The possibility of higher risk of metastasis has also been&#xD;
      reported.&#xD;
&#xD;
      The purpose of our study is to compare the opioid-free general anesthesia with the&#xD;
      opioid-based general anesthesia with respect to the quality of recovery, postoperative pain&#xD;
      and cancer recurrence and metastasis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2020</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>quality of recovery</measure>
    <time_frame>24 hours after surgery</time_frame>
    <description>15-item 15-item 15-item quality of recovery questionnaire</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>health related quality of life</measure>
    <time_frame>up to 3 months after surgery</time_frame>
    <description>evaluated using EuroQol 5 dimensions questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative pain</measure>
    <time_frame>up to 3 months after surgery</time_frame>
    <description>Numeric Rating Scale pain scores, pain questionnaires</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cancer recurrence and metastasis</measure>
    <time_frame>up to 12 months after surgery</time_frame>
    <description>diagnosed by breast cancer specialist</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">78</enrollment>
  <condition>Opioid Free Anesthesia</condition>
  <arm_group>
    <arm_group_label>nerve block+opioid-free general anesthesia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Paravertebral block with an ultrasound-guided technique; opioid-free general anesthesia</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham bock+opioid general anesthesia</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham block by local infiltration at the same site of paravertebral block; opioid based general aneshesia</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>paravertebral block</intervention_name>
    <description>Paravertebral block will be performed at T2,T4 level on the surgical side using out-of-plane approach under ultrasound-guided, with 0.4% ropivacaine 20ml at each injection site.</description>
    <arm_group_label>nerve block+opioid-free general anesthesia</arm_group_label>
    <other_name>nerve block</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>opioid free anesthesia</intervention_name>
    <description>propofol, lidocine and muscle relaxant will be used for induction, after laryngeal mask airway insertion, general anesthesia will be maintained.</description>
    <arm_group_label>nerve block+opioid-free general anesthesia</arm_group_label>
    <other_name>opioid free</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>sham block</intervention_name>
    <description>Local infiltration at the same site of paravertebral block will be performed, with 1% lidocaine 3ml on each injection site.</description>
    <arm_group_label>sham bock+opioid general anesthesia</arm_group_label>
    <other_name>local infiltration</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>opioid general anesthesia</intervention_name>
    <description>propofol, sufentanil and muscle relaxant will be used for induction, after laryngeal mask airway insertion, general anesthesia will be maintained .</description>
    <arm_group_label>sham bock+opioid general anesthesia</arm_group_label>
    <other_name>traditional general aneshesia</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. first diagnosis of histologically confirmed primary breast cancer;&#xD;
&#xD;
          2. undergoing radical mastectomy;&#xD;
&#xD;
          3. patients with I or II staging based on TNM staging system;&#xD;
&#xD;
          4. ASA physical statue I-II;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. chronic pain and opioid administration history;&#xD;
&#xD;
          2. allergy to local anesthetics or NSAIDs;&#xD;
&#xD;
          3. coagulation disorders;&#xD;
&#xD;
          4. local infection at regional block site;&#xD;
&#xD;
          5. unable to comply to study protocol schedule for logistic or other reasons;&#xD;
&#xD;
          6. refusal to participate to the study&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yi Feng, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yi Feng, MD,PhD</last_name>
    <phone>86-010-88325581</phone>
    <email>littlevon@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yi Feng, MD,PhD</last_name>
      <phone>86-010-88325581</phone>
      <email>yifeng65@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <results_reference>
    <citation>Tripathy S, Rath S, Agrawal S, Rao PB, Panda A, Mishra TS, Nayak S. Opioid-free anesthesia for breast cancer surgery: An observational study. J Anaesthesiol Clin Pharmacol. 2018 Jan-Mar;34(1):35-40. doi: 10.4103/joacp.JOACP_143_17.</citation>
    <PMID>29643620</PMID>
  </results_reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>May 8, 2020</study_first_submitted>
  <study_first_submitted_qc>May 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2020</study_first_posted>
  <last_update_submitted>November 26, 2020</last_update_submitted>
  <last_update_submitted_qc>November 26, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">December 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University People's Hospital</investigator_affiliation>
    <investigator_full_name>Yi Feng, MD</investigator_full_name>
    <investigator_title>Chief of the Anesthesiology Department</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Analgesics, Opioid</mesh_term>
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

